title: Hyperprolactinemia in association with subclinical hypothyroidism.
abstract: BACKGROUND
  Hyperprolactinemia is the most common endocrine disorder in hypothalamic-pituitary axis and has been reported in variable levels in patients with overt primary hypothyroidism. We decided to determine the prevalence of hyperprolactinemia and clinical related symptoms in subclinical hypothyroidism patients.
  
  
  METHODS
  In this cross sectional study, prolactin levels of 481 subclinical hypothyroid patients were assessed. Prolactin measurement was performed using chemiluminescent immunoassay. Data were collected and analyzed.
  
  
  RESULTS
  Sixty-two (13%) patients were males and 419 (87%) were females. The mean age of the patients was 32.53±10.13 years. Ninty-eight patients (91 females 7 males) had high prolactin. Prevalence of hyperprolactinemia in subclinical hypothyroidism was 20.4%. (11% in men and 22% in women, p=0.05). There was no correlation between the serum TSH and prolactin level. Clinical symptom prevalence was not different between patients with and without hyperprolactinemia.
  
  
  CONCLUSIONS
  This study showed that prevalence of hyperprolactinemia in subclinical hypothyroidism is notable and this disorder is more common in female subclinical hypothyroidism than the men.
authors.affiliation: Department of Internal Medicine, Imam Khomeini Hospital, Mazandaran University of Medical, Sciences, Sari, Iran.
authors.forename: Adele
authors.initials: A
authors.lastname: Bahar
authors.forename: Ozra
authors.initials: O
authors.lastname: Akha
authors.forename: Zahra
authors.initials: Z
authors.lastname: Kashi
authors.forename: Zakiie
authors.initials: Z
authors.lastname: Vesgari
keywords: Clinical symptom; Hyperprolactinemia; Subclinical hypothyroidism
references.citation: Clin Endocrinol (Oxf). 2003 Feb;58(2):185-91
references.pmid: 12580934
references.citation: Ann Intern Med. 1984 Jul;101(1):18-24
references.pmid: 6428290
references.citation: Am J Psychiatry. 1993 Mar;150(3):508-10
references.pmid: 8434671
references.citation: Arch Intern Med. 2000 Feb 28;160(4):526-34
references.pmid: 10695693
references.citation: Am J Med. 1992 Jun;92(6):631-42
references.pmid: 1605145
references.citation: J Endocrinol Invest. 1999 Oct;22(9):693-7
references.pmid: 10595833
references.citation: N Engl J Med. 1999 Aug 19;341(8):549-55
references.pmid: 10451459
references.citation: Obstet Gynecol. 2005 Feb;105(2):239-45
references.pmid: 15684146
references.citation: Hum Reprod. 1997 May;12(5):896-904
references.pmid: 9194636
references.citation: Obstet Gynecol. 1987 Nov;70(5):789-98
references.pmid: 3309753
references.citation: Thyroid. 2003 Oct;13(10):979-85
references.pmid: 14611708
references.citation: J Clin Endocrinol Metab. 2002 Feb;87(2):489-99
references.pmid: 11836274
references.citation: Am J Med. 2006 Jul;119(7):541-51
references.pmid: 16828622
references.citation: Curr Opin Endocrinol Diabetes Obes. 2007 Jun;14(3):197-208
references.pmid: 17940439
references.citation: Gynecol Endocrinol. 1991 Mar;5(1):15-32
references.pmid: 1680269
references.citation: Am J Med. 1978 May;64(5):782-7
references.pmid: 645742
references.citation: Endocr J. 2010;57(12):1011-5
references.pmid: 20938100
references.citation: J Clin Endocrinol Metab. 1973 Sep;37(3):488-90
references.pmid: 4206493
references.citation: Clin Endocrinol (Oxf). 1999 Feb;50(2):149-55
references.pmid: 10396355
references.citation: JAMA. 2004 Jan 14;291(2):228-38
references.pmid: 14722150
references.citation: J Reprod Med. 1999 May;44(5):455-7
references.pmid: 10360260
references.citation: Thyroid. 2002 May;12(5):421-5
references.pmid: 12097204